An infection of TaY cells, which originated from an adult T-cell leukemia, with an HHV-6B OK isolate resulted in a chronically infected culture, termed TaY(OK). Cell cloning analysis revealed that the TaY(OK) culture consisted of a mixture of cells permissive and refractory to the infection, and that the permissive cells were continuously produced from the refractory cell population. Since the chronically infected culture has been maintained for over 2 years without the addition of uninfected Tay cells, we used it for an evaluation of the antiviral potency of nucleoside analogs, especially carbocyclic oxetanocins (C.OXTs). MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assays showed a lack of toxicity of ganciclovir (GCV), C.OXTs, and their derivatives, to TaY(OK) cells at 1 μM. Therefore we compared the antiviral potencies of these drugs at 1 μM by monitoring the viral loads produced during a 1-day period during the course of the drug treatment. Among the drugs tested, 3′-fluorocarbocyclic oxetanocin A (3′FC.OXT-A) was the most effective for inhibiting the virus production, and at concentrations ranging from 0.5 μM to 10 μM, the inhibition of the viral production was dose-dependent. A comparison of the chemical structures of the derivatives with that of C.OXT-A, which is the parental molecule, suggested that the 3′-fluorine-modification might account for the higher anti-HHV-6 activity and lower cytotoxicity.
|Number of pages||10|
|Journal||MICROBIOLOGY and IMMUNOLOGY|
|Publication status||Published - 2001|
- 3′-Fluorocarbocyclic oxetanocin A
- Chronic infection
ASJC Scopus subject areas